Research Studies
Back to Results
NRG-GY020: A PHASE III RANDOMIZED TRIAL OF RADIATION +/- PEMBROLIZUMAB (MK-3475) FOR NEWLY DIAGNOSED EARLY STAGE HIGH INTERMEDIATE RISK MISMATCH REPAIR DEFICIENT (dMMR) ENDOMETRIOID ENDOMETRIAL CANCER
Details
Age
Adult
Type of Study
Treatment
Locations
Highlands Ranch Hospital
Memorial Hospital Central
Memorial Hospital North
University of Colorado Hospital
Principal Investigator
Bradley Corr, MD
Study ID
Protocol Number: 21-3887
More information available at ClinicalTrials.gov: NCT04214067
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers